Stark H - Search Results

1

Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H₃ Receptor Antagonists and Monoamine Oxidase B Inhibitors.

Łażewska D, Olejarz-Maciej A, Reiner D, Kaleta M, Latacz G, Zygmunt M, Doroz-Płonka A, Karcz T, Frank A, Stark H, Kieć-Kononowicz K. Łażewska D, et al. Among authors: stark h. Int J Mol Sci. 2020 May 12;21(10):3411. doi: 10.3390/ijms21103411. Int J Mol Sci. 2020. PMID: 32408504 Free PMC article.

2

Azines and diazines as potential histamine H3-receptor antagonists.

Kieć-Kononowicz K, Ligneau X, Stark H, Schwartz JC, Schunack W. Kieć-Kononowicz K, et al. Among authors: stark h. Arch Pharm (Weinheim). 1995 May;328(5):445-50. doi: 10.1002/ardp.19953280509. Arch Pharm (Weinheim). 1995. PMID: 7611840

3

Development of a binding site model for histamine H3-receptor agonists.

Sippl W, Stark H, Höltje HD. Sippl W, et al. Among authors: stark h. Pharmazie. 1998 Jul;53(7):433-7. Pharmazie. 1998. PMID: 9699219

4

Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.

Sasse A, Kiec-Kononowicz K, Stark H, Motyl M, Reidemeister S, Ganellin CR, Ligneau X, Schwartz JC, Schunack W. Sasse A, et al. Among authors: stark h. J Med Chem. 1999 Feb 25;42(4):593-600. doi: 10.1021/jm9804376. J Med Chem. 1999. PMID: 10052966

5

Piperidine-containing histamine H3-receptor antagonists of the carbamate series: variation of the spacer length.

Łazewska D, Kieć-Kononowicz K, Pertz HH, Stark H, Schunack W, Elz S. Łazewska D, et al. Among authors: stark h. Pharmazie. 2001 Dec;56(12):927-32. Pharmazie. 2001. PMID: 11802653

6

Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity.

Kieć-Kononowicz K, Wiecek M, Sasse A, Ligneau X, Elz S, Ganellin CR, Schwartz JC, Stark H, Schunack W. Kieć-Kononowicz K, et al. Among authors: stark h. Pharmazie. 2000 May;55(5):349-55. Pharmazie. 2000. PMID: 11828613

7

Impact of lipophilicity on the pharmacological properties of histamine H3-receptor antagonists of the cycloalkyl carbamate class.

Wiecek M, Kieć-Kononowicz K, Sasse A, Ligneau X, Schwartz JC, Schunack W, Stark H. Wiecek M, et al. Among authors: stark h. Inflamm Res. 2002 Apr;51 Suppl 1:S71-2. doi: 10.1007/pl00000274. Inflamm Res. 2002. PMID: 12013417 No abstract available.

8

Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the influence of the additional ether functionality.

Łazewska D, Kieć-Kononowicz K, Pertz HH, Elz S, Stark H, Schunack W. Łazewska D, et al. Among authors: stark h. Pharmazie. 2002 Dec;57(12):791-5. Pharmazie. 2002. PMID: 12561236

9

Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the alkyl derivatives.

Lazewska D, Kieć-Kononowicz K, Elz S, Pertz HH, Stark H, Schunack W. Lazewska D, et al. Among authors: stark h. Pharmazie. 2005 Jun;60(6):403-10. Pharmazie. 2005. PMID: 15997826

10

Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists.

Łazewska D, Ligneau X, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K. Łazewska D, et al. Among authors: stark h. Bioorg Med Chem. 2006 May 15;14(10):3522-9. doi: 10.1016/j.bmc.2006.01.013. Epub 2006 Feb 8. Bioorg Med Chem. 2006. PMID: 16466921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,196 results

Search Page

Filters